SweetValueLab
Write for us

Humana Inc. — Wall Street Analyst Estimates & Price Targets

HUM
NYSEHealthcareMedical - Healthcare PlansCIK 0000049071humana.comAbout HUM
Last close · Oct 16, 2026413.33−18.87 (−4.37%)
Market cap$49.6B

14 firms' latest targets, last 90 days: median $487.50 ($370.00–$596.00), 18% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$200$300$400$500$600NovJan 2026MarMayJulSep2025-11-10 · Truist: $2852025-11-25 · Barclays: $2342025-12-05 · Jefferies: $3132025-12-18 · Morgan Stanley: $2622026-01-06 · Bernstein: $3442026-01-07 · Wells Fargo: $2902026-02-02 · Morgan Stanley: $1742026-02-12 · UBS: $1952026-02-12 · Raymond James: $2012026-02-12 · Oppenheimer: $2502026-02-12 · Morgan Stanley: $1462026-02-12 · Guggenheim: $2522026-02-12 · RBC Capital: $1892026-02-13 · Deutsche Bank: $1802026-02-17 · Truist: $2002026-02-18 · Wells Fargo: $2062026-04-08 · Evercore ISI: $1952026-04-08 · Mizuho Securities: $2582026-04-30 · RBC Capital: $2462026-04-30 · Deutsche Bank: $2352026-04-30 · Oppenheimer: $2602026-04-30 · Truist: $2702026-04-30 · Guggenheim: $2692026-04-30 · UBS: $2622026-04-30 · Barclays: $1802026-05-01 · Raymond James: $2602026-05-13 · Piper Sandler: $2542026-05-15 · Morgan Stanley: $2172026-05-20 · Mizuho Securities: $3352026-05-20 · Deutsche Bank: $4412026-05-22 · UBS: $3202026-05-26 · Barclays: $3442026-06-01 · Truist: $3202026-06-03 · Bernstein: $4252026-06-04 · Morgan Stanley: $2492026-06-08 · Mizuho Securities: $3902026-07-07 · Cantor Fitzgerald: $3002026-07-07 · Raymond James: $3002026-07-09 · RBC Capital: $4152026-07-13 · Wells Fargo: $5022026-07-14 · Truist: $4152026-07-20 · Jefferies: $4102026-07-29 · Evercore ISI: $4802026-07-30 · Piper Sandler: $4632026-07-30 · UBS: $4052026-07-30 · Oppenheimer: $4052026-07-30 · Baird: $3902026-07-30 · Guggenheim: $4712026-07-30 · Leerink Partners: $5132026-07-31 · Barclays: $4072026-08-04 · Morgan Stanley: $3702026-08-24 · Wolfe Research: $4502026-09-25 · Barclays: $5152026-10-07 · Raymond James: $4602026-10-09 · Oppenheimer: $4752026-10-09 · Barclays: $5822026-10-09 · UBS: $5962026-10-09 · Baird: $5962026-10-12 · Oppenheimer: $5252026-10-12 · UBS: $4952026-10-12 · Truist: $4752026-10-12 · Raymond James: $5202026-10-13 · Mizuho Securities: $495
$200$300$400$500$600NovFebMayAug

Each firm's latest target

last 90 days · 14 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-13Mizuho Securities$495.00$390.00▲ 27%+14%+20%
2026-10-12Oppenheimer$525.00$475.00▲ 11%+22%+27%
2026-10-12UBS$495.00$596.00▼ 17%+15%+20%
2026-10-12Truist$475.00$415.00▲ 14%+10%+15%
2026-10-12Raymond James$520.00$460.00▲ 13%+21%+26%
2026-10-09Barclays$582.00$515.00▲ 13%+50%+41%
2026-10-09Baird$596.00$390.00▲ 53%+54%+44%
2026-08-24Wolfe Research$450.00——+19%+9%
2026-08-04Morgan Stanley$370.00$249.00▲ 49%+2%-10%
2026-07-30Piper Sandler$463.00$254.00▲ 82%+25%+12%
2026-07-30Guggenheim$471.00$269.00▲ 75%+29%+14%
2026-07-30Leerink Partners$513.00——+40%+24%
2026-07-29Evercore ISI$480.00$195.00▲ 146%+31%+16%
2026-07-20Jefferies$410.00$313.00▲ 31%+3%-1%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$106.4B+15%$20.00-9%est. $104.8B+1%est. $27.1711
2024reported$117.8B+11%$9.98-50%est. $117.0B+1%est. $16.1213
2025reported$129.7B+10%$9.84-1%est. $129.2B+0%est. $17.0916
2026$162.5B+25%$9.16-46%$161.8B–$163.0B$9.04–$9.6116
2027$167.8B+3%$16.96+85%$159.2B–$177.3B$11.00–$21.1716
2028$180.4B+8%$30.52+80%$163.3B–$193.8B$24.40–$40.4719
2029$189.5B+5%$34.91+14%$181.1B–$196.9B$32.90–$36.689
2030$204.6B+8%$35.53+2%$195.6B–$212.6B$33.49–$37.3315
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.